(Q50506553)

14 March 2018

title

A role for the membrane proteome in human chronic kidney disease erythrocytes. (English)

1 reference

14 March 2018

chronic renal insufficiency

main subject

1 reference

5

1 reference

14 March 2018

Fernando De la Cuesta

Fernando de la Cuesta

4

0 references

María G Barderas

María G Barderas

7

0 references

Gloria Alvarez-Llamas

Gloria Alvarez-Llamas

1

0 references

Alberto Ortiz

Alberto Ortiz

10

0 references

author name string

Irene Zubiri

2

1 reference

14 March 2018

Aroa S Maroto

3

1 reference

14 March 2018

Marta Martin-Lorenzo

6

1 reference

14 March 2018

Beatriz Fernandez-Fernandez

8

1 reference

14 March 2018

Ana Ramos

9

1 reference

14 March 2018

Fernando Vivanco

11

1 reference

14 March 2018

publication date

17 July 2012

1 reference

14 March 2018

published in

Translational Research

1 reference

14 March 2018

volume

160

1 reference

14 March 2018

issue

5

1 reference

14 March 2018

page(s)

374-383

1 reference

14 March 2018

Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Correction of anemia with epoetin alfa in chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Red blood cell deformability in renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Effect of dialysis on erythrocyte membrane of chronically hemodialyzed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

A novel methodology for the analysis of membrane and cytosolic sub-proteomes of erythrocytes by 2-DE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Red blood cell survival in long-term dialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Primary structure and domain organization of human alpha and beta adducin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

ERM proteins: from cellular architecture to cell signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Rheological studies during treatment of renal anaemia with recombinant human erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

The required dose of erythropoietin during renal anaemia treatment is related to the degree of impairment in erythrocyte deformability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.06.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2012.06.004

1 reference

14 March 2018

1 reference

14 March 2018